{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:56:33Z","timestamp":1793955393596,"version":"4.8.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12011-6","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:07:13Z","timestamp":1779880033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Translational stem cell therapy for neurodegeneration and CNS trauma: a focused review"],"prefix":"10.1007","volume":"53","author":[{"given":"Rasa","family":"Khosrofar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5495-1565","authenticated-orcid":false,"given":"Parmida","family":"Nafei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sadrmohammadbagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faranak","family":"Zargari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassim","family":"Rastgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvin","family":"Radvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiyereh Alipour","family":"Eskandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Hoseinzade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza Akhavan","family":"Sigari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"1","key":"12011_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/08880018.2024.2420924","volume":"42","author":"TE Knight","year":"2025","unstructured":"Knight TE, Broglie L, Sharma A, Qayed M, Yanik GA (2025) Why are Higher CD34\u2009+\u2009Cell Doses Associated with Improved Outcomes among Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors - But Not for High-Risk Neuroblastoma? Pediatr Hematol Oncol 42(1):63\u201367","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"12011_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/17435889.2024.2421157","volume":"20","author":"AG Almutary","year":"2025","unstructured":"Almutary AG, Chauhan P, Baldaniya L, Menon SV, Kumar MR, Chaturvedi B et al (2025) Overcoming challenges in the design of drug delivery systems targeting the central nervous system. Nanomed (London England) 20(1):5\u20138","journal-title":"Nanomed (London England)"},{"issue":"23","key":"12011_CR3","first-page":"1822","volume":"7","author":"R Sakthiswary","year":"2012","unstructured":"Sakthiswary R, Raymond AA (2012) Stem cell therapy in neurodegenerative diseases: From principles to practice. Neural regeneration Res 7(23):1822\u20131831","journal-title":"Neural regeneration Res"},{"issue":"7\u20138","key":"12011_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1089\/neu.2024.0544","volume":"42","author":"SL Schantz","year":"2025","unstructured":"Schantz SL, Duberstein KJ, Kaiser EE, West FD (2025) Human Neural Stem Cell Therapy for Traumatic Brain Injury-A Systematic Review of Pre-Clinical Studies. J Neurotrauma 42(7\u20138):668\u2013688","journal-title":"J Neurotrauma"},{"key":"12011_CR5","doi-asserted-by":"crossref","unstructured":"Narasimha RB, Shreya S, Jayabal VA, Yadav V, Rath PK, Mishra BP et al (2025) Stem Cell Therapy for Diseases of Livestock Animals: An In-Depth Review. Veterinary Sci 12(1)","DOI":"10.3390\/vetsci12010067"},{"issue":"11","key":"12011_CR6","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.4103\/NRR.NRR-D-24-00901","volume":"20","author":"S Vidman","year":"2025","unstructured":"Vidman S, Ma YHE, Fullenkamp N, Plant GW (2025) Human induced pluripotent stem cell-derived therapies for regeneration after central nervous system injury. Neural regeneration Res 20(11):3063\u20133075","journal-title":"Neural regeneration Res"},{"key":"12011_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/NDT.S497758","volume":"21","author":"H Cai","year":"2025","unstructured":"Cai H, Huang J, Wang W, Lin W, Ahmed W, Lu D et al (2025) Characteristics of Parthenogenetic Stem Cells and Their Potential Treatment Strategy for Central Nervous System Diseases. Neuropsychiatr Dis Treat 21:213\u2013227","journal-title":"Neuropsychiatr Dis Treat"},{"key":"12011_CR8","doi-asserted-by":"crossref","unstructured":"Xun X, Hao J, Cheng Q, Gao P (2025) Induced Pluripotent Stem Cell-Based Cancer Immunotherapy: Strategies and Perspectives. Biomedicines 13(8)","DOI":"10.3390\/biomedicines13082012"},{"issue":"3","key":"12011_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/CIRCRESAHA.111.249243","volume":"112","author":"PE de Almeida","year":"2013","unstructured":"de Almeida PE, Ransohoff JD, Nahid A, Wu JC (2013) Immunogenicity of pluripotent stem cells and their derivatives. Circul Res 112(3):549\u2013561","journal-title":"Circul Res"},{"key":"12011_CR10","doi-asserted-by":"crossref","unstructured":"Zhang H, Zhou H, Xia X, Cao Q, Liu Y (2025) Hypoimmunogenic Human iPSCs for Repair and Regeneration in the CNS. Cells 14(16)","DOI":"10.3390\/cells14161248"},{"issue":"4","key":"12011_CR11","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s00415-018-8818-7","volume":"265","author":"D McLauchlan","year":"2018","unstructured":"McLauchlan D, Robertson NP (2018) Stem cells in the treatment of central nervous system disease. J Neurol 265(4):984\u2013986","journal-title":"J Neurol"},{"issue":"9","key":"12011_CR12","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1038\/s41380-020-0786-5","volume":"26","author":"JZ Yu","year":"2021","unstructured":"Yu JZ, Wang J, Sheridan SD, Perlis RH, Rasenick MM (2021) N-3 polyunsaturated fatty acids promote astrocyte differentiation and neurotrophin production independent of cAMP in patient-derived neural stem cells. Mol Psychiatry 26(9):4605\u20134615","journal-title":"Mol Psychiatry"},{"issue":"6","key":"12011_CR13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/cns.13247","volume":"26","author":"T Yasuhara","year":"2020","unstructured":"Yasuhara T, Kawauchi S, Kin K, Morimoto J, Kameda M, Sasaki T et al (2020) Cell therapy for central nervous system disorders: Current obstacles to progress. CNS Neurosci Ther 26(6):595\u2013602","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"12011_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4062\/biomolther.2019.065","volume":"28","author":"R Hern\u00e1ndez","year":"2020","unstructured":"Hern\u00e1ndez R, Jim\u00e9nez-Luna C, Perales-Ad\u00e1n J, Perazzoli G, Melguizo C, Prados J (2020) Differentiation of Human Mesenchymal Stem Cells towards Neuronal Lineage: Clinical Trials in Nervous System Disorders. Biomolecules Ther 28(1):34\u201344","journal-title":"Biomolecules Ther"},{"issue":"8","key":"12011_CR15","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/mt.2016.104","volume":"24","author":"X Li","year":"2016","unstructured":"Li X, Zhang Y, Yan Y, Ciric B, Ma C-G, Gran B et al (2016) Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity. Mol Ther 24(8):1456","journal-title":"Mol Ther"},{"issue":"7","key":"12011_CR16","first-page":"2002944","volume":"8","author":"A Andrzejewska","year":"2021","unstructured":"Andrzejewska A, Dabrowska S, Lukomska B, Janowski M (2021) Mesenchymal Stem Cells for Neurological Disorders. Adv Sci (Weinheim Baden-Wurttemberg Germany) 8(7):2002944","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"issue":"1","key":"12011_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40035-023-00385-7","volume":"12","author":"P Zou","year":"2023","unstructured":"Zou P, Wu C, Liu TC, Duan R, Yang L (2023) Oligodendrocyte progenitor cells in Alzheimer\u2019s disease: from physiology to pathology. Translational neurodegeneration 12(1):52","journal-title":"Translational neurodegeneration"},{"issue":"8","key":"12011_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0166-2236(99)01428-9","volume":"22","author":"CN Svendsen","year":"1999","unstructured":"Svendsen CN, Smith AG (1999) New prospects for human stem-cell therapy in the nervous system. Trends Neurosci 22(8):357\u2013364","journal-title":"Trends Neurosci"},{"issue":"5","key":"12011_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrgastro.2013.226","volume":"11","author":"AJ Burns","year":"2014","unstructured":"Burns AJ, Thapar N (2014) Neural stem cell therapies for enteric nervous system disorders. Nat reviews Gastroenterol Hepatol 11(5):317\u2013328","journal-title":"Nat reviews Gastroenterol Hepatol"},{"issue":"10","key":"12011_CR20","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/sctm.19-0430","volume":"9","author":"B Badyra","year":"2020","unstructured":"Badyra B, Su\u0142kowski M, Milczarek O, Majka M (2020) Mesenchymal stem cells as a multimodal treatment for nervous system diseases. Stem cells translational Med 9(10):1174\u20131189","journal-title":"Stem cells translational Med"},{"issue":"8","key":"12011_CR21","doi-asserted-by":"publisher","first-page":"107717","DOI":"10.4252\/wjsc.v17.i8.107717","volume":"17","author":"CX Cui","year":"2025","unstructured":"Cui CX, Shao XN, Li YY, Qiao L, Lin JT, Guan LH (2025) Therapeutic potential of mesenchymal stem cells in neurodegenerative diseases. World J stem cells 17(8):107717","journal-title":"World J stem cells"},{"issue":"5","key":"12011_CR22","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1177\/1073858420954826","volume":"27","author":"I Decimo","year":"2021","unstructured":"Decimo I, Dolci S, Panuccio G, Riva M, Fumagalli G, Bifari F (2021) Meninges: A Widespread Niche of Neural Progenitors for the Brain. Neuroscientist: Rev J bringing Neurobiol Neurol psychiatry 27(5):506\u2013528","journal-title":"Neuroscientist: Rev J bringing Neurobiol Neurol psychiatry"},{"issue":"5","key":"12011_CR23","doi-asserted-by":"publisher","first-page":"e23288","DOI":"10.1002\/dvg.23288","volume":"57","author":"K Dasgupta","year":"2019","unstructured":"Dasgupta K, Jeong J (2019) Developmental biology of the meninges. Genesis (New York NY: 2000) 57(5):e23288","journal-title":"Genesis (New York NY: 2000)"},{"issue":"3","key":"12011_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.stem.2016.10.020","volume":"20","author":"F Bifari","year":"2017","unstructured":"Bifari F, Decimo I, Pino A, Llorens-Bobadilla E, Zhao S, Lange C et al (2017) Neurogenic Radial Glia-like Cells in Meninges Migrate and Differentiate into Functionally Integrated Neurons in the Neonatal Cortex. Cell Stem Cell 20(3):360\u201373e7","journal-title":"Cell Stem Cell"},{"issue":"1","key":"12011_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13024-017-0227-3","volume":"12","author":"Y Ciervo","year":"2017","unstructured":"Ciervo Y, Ning K, Jun X, Shaw PJ, Mead RJ (2017) Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis. Mol neurodegeneration 12(1):85","journal-title":"Mol neurodegeneration"},{"key":"12011_CR26","doi-asserted-by":"publisher","first-page":"2853650","DOI":"10.1155\/2020\/2853650","volume":"2020","author":"L Gao","year":"2020","unstructured":"Gao L, Peng Y, Xu W, He P, Li T, Lu X et al (2020) Progress in Stem Cell Therapy for Spinal Cord Injury. Stem cells Int 2020:2853650","journal-title":"Stem cells Int"},{"issue":"1","key":"12011_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s43556-024-00239-2","volume":"6","author":"Y Gu","year":"2025","unstructured":"Gu Y, Yang R, Zhang Y, Guo M, Takehiro K, Zhan M et al (2025) Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer. Mol Biomed 6(1):2","journal-title":"Mol Biomed"},{"key":"12011_CR28","doi-asserted-by":"crossref","unstructured":"Kaminska A, Radoszkiewicz K, Rybkowska P, Wedzinska A, Sarnowska A (2022) Interaction of Neural Stem Cells (NSCs) and Mesenchymal Stem Cells (MSCs) as a Promising Approach in Brain Study and Nerve Regeneration. Cells 11(9)","DOI":"10.3390\/cells11091464"},{"issue":"Pt 1","key":"12011_CR29","doi-asserted-by":"publisher","first-page":"140387","DOI":"10.1016\/j.ijbiomac.2025.140387","volume":"304","author":"K Marzookian","year":"2025","unstructured":"Marzookian K, Aliakbari F, Hourfar H, Sabouni F, Otzen DE, Morshedi D (2025) The neuroprotective effect of human umbilical cord MSCs-derived secretome against \u03b1-synuclein aggregates on the blood-brain barrier. Int J Biol Macromol 304(Pt 1):140387","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"12011_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nrneurol.2010.73","volume":"6","author":"V Sahni","year":"2010","unstructured":"Sahni V, Kessler JA (2010) Stem cell therapies for spinal cord injury. Nat reviews Neurol 6(7):363\u2013372","journal-title":"Nat reviews Neurol"},{"key":"12011_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/cells11213476","volume":"11","author":"MA Zayed","year":"2022","unstructured":"Zayed MA, Sultan S, Alsaab HO, Yousof SM, Alrefaei GI, Alsubhi NH et al (2022) Stem-Cell-Based Therapy: The Celestial Weapon against Neurological Disorders. Cells 11:21","journal-title":"Cells"},{"issue":"5","key":"12011_CR32","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00018-008-8346-1","volume":"66","author":"F Locatelli","year":"2009","unstructured":"Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, Strazzer S et al (2009) Stem cell therapy in stroke. Cell Mol Life Sci 66(5):757\u2013772","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"12011_CR33","doi-asserted-by":"publisher","first-page":"8002","DOI":"10.1097\/JS9.0000000000002109","volume":"110","author":"BM Hussen","year":"2024","unstructured":"Hussen BM, Taheri M, Yashooa RK, Abdullah GH, Abdullah SR, Kheder RK et al (2024) Revolutionizing medicine: recent developments and future prospects in stem-cell therapy. Int J Surg (London England) 110(12):8002\u20138024","journal-title":"Int J Surg (London England)"},{"issue":"5","key":"12011_CR34","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s12015-013-9443-6","volume":"9","author":"PL Mart\u00ednez-Morales","year":"2013","unstructured":"Mart\u00ednez-Morales PL, Revilla A, Oca\u00f1a I, Gonz\u00e1lez C, Sainz P, McGuire D et al (2013) Progress in stem cell therapy for major human neurological disorders. Stem cell reviews Rep 9(5):685\u2013699","journal-title":"Stem cell reviews Rep"},{"key":"12011_CR35","doi-asserted-by":"crossref","unstructured":"Szymoniuk M, Litak J, Sakwa L, Dryla A, Zezuli\u0144ski W, Czy\u017cewski W et al (2022) Molecular Mechanisms and Clinical Application of Multipotent Stem Cells for Spinal Cord Injury. Cells 12(1)","DOI":"10.3390\/cells12010120"},{"key":"12011_CR36","doi-asserted-by":"publisher","first-page":"103495","DOI":"10.1016\/j.scr.2024.103495","volume":"79","author":"D Hern\u00e1ndez","year":"2024","unstructured":"Hern\u00e1ndez D, Schlicht SM, Clarke JE, Daniszewski M, Karch CM, Adams S et al (2024) Generation of a gene-corrected human isogenic iPSC line from an Alzheimer\u2019s disease iPSC line carrying the PSEN1 H163R mutation. Stem cell Res 79:103495","journal-title":"Stem cell Res"},{"issue":"7","key":"12011_CR37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2174\/092986710790416272","volume":"17","author":"A Orlacchio","year":"2010","unstructured":"Orlacchio A, Bernardi G, Orlacchio A, Martino S (2010) Stem cells: an overview of the current status of therapies for central and peripheral nervous system diseases. Curr Med Chem 17(7):595\u2013608","journal-title":"Curr Med Chem"},{"issue":"11 Suppl 3","key":"12011_CR38","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1097\/PHM.0000000000000111","volume":"93","author":"AR Maldonado-Soto","year":"2014","unstructured":"Maldonado-Soto AR, Oakley DH, Wichterle H, Stein J, Doetsch FK, Henderson CE (2014) Stem cells in the nervous system. Am J Phys Med Rehabil 93(11 Suppl 3):S132\u2013S144","journal-title":"Am J Phys Med Rehabil"},{"issue":"5","key":"12011_CR39","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2174\/011574888X341525250116052000","volume":"20","author":"K Singh","year":"2025","unstructured":"Singh K, Singh G, Gupta JK, Choudhary AN, Kumar A, Jain D et al (2025) Molecular Mechanisms and Pathways of Mesenchymal Stem Cell-mediated Therapy in Brain Cancer. Curr Stem Cell Res Therapy 20(5):479\u2013493","journal-title":"Curr Stem Cell Res Therapy"},{"key":"12011_CR40","doi-asserted-by":"crossref","unstructured":"Garg A, Goel K, Gour A, Sapra M, Sangwan VS, Tripathi R et al (2025) Unveiling the Molecular Mechanisms Underlying the Success of Simple Limbal Epithelial Transplantation (SLET). Cells 14(3)","DOI":"10.3390\/cells14030200"},{"issue":"12","key":"12011_CR41","doi-asserted-by":"publisher","first-page":"e70540","DOI":"10.1002\/mco2.70540","volume":"6","author":"XY Guo","year":"2025","unstructured":"Guo XY, Song DY, Wu MY, Zhang JQ, Li JY, Yuan L (2025) Parkinson\u2019s Disease: The Epidemiology, Risk Factors, Molecular Pathogenesis, Prevention, and Therapy. MedComm 6(12):e70540","journal-title":"MedComm"},{"key":"12011_CR42","doi-asserted-by":"crossref","unstructured":"Brodski C, Blaess S, Partanen J, Prakash N (2019) Crosstalk of Intercellular Signaling Pathways in the Generation of Midbrain Dopaminergic Neurons In Vivo and from Stem Cells. J Dev biology 7(1)","DOI":"10.3390\/jdb7010003"},{"key":"12011_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1749-8104-6-23","volume":"6","author":"MT Alves dos Santos","year":"2011","unstructured":"Alves dos Santos MT, Smidt MP (2011) En1 and Wnt signaling in midbrain dopaminergic neuronal development. Neural Dev 6:23","journal-title":"Neural Dev"},{"issue":"9","key":"12011_CR44","doi-asserted-by":"publisher","first-page":"e0320367","DOI":"10.1371\/journal.pone.0320367","volume":"20","author":"H Faghih","year":"2025","unstructured":"Faghih H, Javeri A, Taha MF (2025) Decellularized rat brain extracellular matrix effectively induces the dopaminergic differentiation of human adipose-derived stem cells. PLoS ONE 20(9):e0320367","journal-title":"PLoS ONE"},{"issue":"11","key":"12011_CR45","doi-asserted-by":"publisher","first-page":"e12519","DOI":"10.1002\/jev2.12519","volume":"13","author":"LN Madhu","year":"2024","unstructured":"Madhu LN, Kodali M, Upadhya R, Rao S, Somayaji Y, Attaluri S et al (2024) Extracellular vesicles from human-induced pluripotent stem cell-derived neural stem cells alleviate proinflammatory cascades within disease-associated microglia in Alzheimer\u2019s disease. J Extracell vesicles 13(11):e12519","journal-title":"J Extracell vesicles"},{"issue":"8064","key":"12011_CR46","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","volume":"641","author":"V Tabar","year":"2025","unstructured":"Tabar V, Sarva H, Lozano AM, Fasano A, Kalia SK, Yu KKH et al (2025) Phase I trial of hES cell-derived dopaminergic neurons for Parkinson\u2019s disease. Nature 641(8064):978\u2013983","journal-title":"Nature"},{"issue":"1","key":"12011_CR47","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1038\/s41467-020-17165-w","volume":"11","author":"D Doi","year":"2020","unstructured":"Doi D, Magotani H, Kikuchi T, Ikeda M, Hiramatsu S, Yoshida K et al (2020) Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson\u2019s disease. Nat Commun 11(1):3369","journal-title":"Nat Commun"},{"issue":"1","key":"12011_CR48","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/s40001-025-02886-9","volume":"30","author":"J Zhang","year":"2025","unstructured":"Zhang J, Kong G, Yang J, Pang L, Li X (2025) Pathological mechanisms and treatment progression of Alzheimer\u2019s disease. Eur J Med Res 30(1):625","journal-title":"Eur J Med Res"},{"issue":"12","key":"12011_CR49","first-page":"2612","volume":"30","author":"WW Chen","year":"2012","unstructured":"Chen WW, Blurton-Jones M (2012) Concise review: Can stem cells be used to treat or model Alzheimer\u2019s disease? Stem cells (Dayton. Ohio) 30(12):2612\u20132618","journal-title":"Ohio)"},{"issue":"2","key":"12011_CR50","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2174\/1567205013666160314145347","volume":"14","author":"P Bali","year":"2017","unstructured":"Bali P, Lahiri DK, Banik A, Nehru B, Anand A (2017) Potential for Stem Cells Therapy in Alzheimer\u2019s Disease: Do Neurotrophic Factors Play Critical Role? Curr Alzheimer Res 14(2):208\u2013220","journal-title":"Curr Alzheimer Res"},{"key":"12011_CR51","doi-asserted-by":"crossref","unstructured":"El-Derany MO, AbdelHamid SG (2022) Bone Marrow Mesenchymal Stem Cells and Their Derived Extracellular Vesicles Attenuate Non-Alcoholic Steatohepatitis-Induced Cardiotoxicity via Modulating Cardiac Mechanisms. Life (Basel Switzerland) 12(3)","DOI":"10.3390\/life12030355"},{"issue":"1","key":"12011_CR52","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s12013-014-0222-z","volume":"71","author":"W Ge","year":"2015","unstructured":"Ge W, Ren C, Duan X, Geng D, Zhang C, Liu X et al (2015) Differentiation of mesenchymal stem cells into neural stem cells using cerebrospinal fluid. Cell Biochem Biophys 71(1):449\u2013455","journal-title":"Cell Biochem Biophys"},{"key":"12011_CR53","doi-asserted-by":"crossref","unstructured":"Inamdar A, Gurupadayya B, Sharma H (2025) The Role of Glial Cells in Autism Spectrum Disorder: Molecular Mechanisms and Therapeutic Approaches. CNS & neurological disorders drug targets","DOI":"10.2174\/0118715273337007241115102118"},{"key":"12011_CR54","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.reth.2022.08.003","volume":"21","author":"C Ardianto","year":"2022","unstructured":"Ardianto C, Shen R, Barus JFA, Sasmita PK, Turana Y, Lilis L et al (2022) Secretome as neuropathology-targeted intervention of Parkinson\u2019s disease. Regenerative therapy 21:288\u2013293","journal-title":"Regenerative therapy"},{"key":"12011_CR55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fncel.2017.00080","volume":"11","author":"R Bonafede","year":"2017","unstructured":"Bonafede R, Mariotti R (2017) ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles. Front Cell Neurosci 11:80","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"12011_CR56","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/13543784.2019.1627324","volume":"28","author":"SA Goutman","year":"2019","unstructured":"Goutman SA, Savelieff MG, Sakowski SA, Feldman EL (2019) Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials. Expert Opin Investig Drugs 28(6):525\u2013543","journal-title":"Expert Opin Investig Drugs"},{"key":"12011_CR57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/biom13081250","volume":"13","author":"M Kandeel","year":"2023","unstructured":"Kandeel M, Morsy MA, Alkhodair KM, Alhojaily S (2023) Mesenchymal Stem Cell-Derived Extracellular Vesicles: An Emerging Diagnostic and Therapeutic Biomolecules for Neurodegenerative Disabilities. Biomolecules 13:8","journal-title":"Biomolecules"},{"issue":"9","key":"12011_CR58","doi-asserted-by":"publisher","first-page":"e70460","DOI":"10.1002\/jbt.70460","volume":"39","author":"T Liu","year":"2025","unstructured":"Liu T, Li X (2025) The Crosstalk Between Protective and Detrimental Interleukin (IL)-1 Family of Cytokines in Alzheimer\u2019s Disease. J Biochem Mol Toxicol 39(9):e70460","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"12011_CR59","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-024-02044-3","volume":"10","author":"H Wen","year":"2025","unstructured":"Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X et al (2025) Mitochondrial diseases: from molecular mechanisms to therapeutic advances. Signal Transduct Target therapy 10(1):9","journal-title":"Signal Transduct Target therapy"},{"key":"12011_CR60","doi-asserted-by":"crossref","unstructured":"Barbalho SM, Leme Boaro B, da Silva Camarinha Oliveira J, Pato\u010dka J, Barbalho Lamas C, Tanaka M et al (2025) Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature. Pharmaceuticals (Basel Switzerland) 18(1)","DOI":"10.3390\/ph18010133"},{"issue":"1","key":"12011_CR61","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3344\/kjp.25166","volume":"39","author":"W Pu","year":"2026","unstructured":"Pu W, Zhou L, Liu R, Li S, Wang S, Cao S (2026) Microglia-derived neuroinflammatory pathways in neuropathic pain. Korean J pain 39(1):4\u201335","journal-title":"Korean J pain"},{"issue":"2","key":"12011_CR62","doi-asserted-by":"publisher","first-page":"100275","DOI":"10.1016\/j.jnrt.2026.100275","volume":"14","author":"X Gu","year":"2026","unstructured":"Gu X, Bao Q, Peng J, Yuan J (2026) Research progress on the pathological mechanisms and clinical treatment of spinal cord ischemia\u2013reperfusion injury. J Neurorestoratology 14(2):100275","journal-title":"J Neurorestoratology"},{"issue":"12","key":"12011_CR63","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1172\/JCI37914","volume":"119","author":"J Yang","year":"2009","unstructured":"Yang J, Jiang Z, Fitzgerald DC, Ma C, Yu S, Li H et al (2009) Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis. J Clin Investig 119(12):3678\u20133691","journal-title":"J Clin Investig"},{"issue":"14","key":"12011_CR64","doi-asserted-by":"publisher","first-page":"R713","DOI":"10.1016\/j.cub.2017.05.064","volume":"27","author":"NJ Vickers","year":"2017","unstructured":"Vickers NJ (2017) Animal communication: when i\u2019m calling you, will you answer too? Curr Biol 27(14):R713\u2013R5","journal-title":"Curr Biol"},{"key":"12011_CR65","doi-asserted-by":"publisher","first-page":"1362494","DOI":"10.3389\/fncel.2024.1362494","volume":"18","author":"Y Gao","year":"2024","unstructured":"Gao Y, Wang Y, Wu Y, Liu S (2024) Biomaterials targeting the microenvironment for spinal cord injury repair: progression and perspectives. Front Cell Neurosci 18:1362494","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"12011_CR66","doi-asserted-by":"publisher","first-page":"7484","DOI":"10.1007\/s12035-025-04714-x","volume":"62","author":"W Shah","year":"2025","unstructured":"Shah W, Gong Y, Qiao X, Lu Y, Ding Y, Zhang Z et al (2025) Exploring Endothelial Cell Dysfunction\u2019s Impact on the Brain-Retina Microenvironment Connection: Molecular Mechanisms and Implications. Mol Neurobiol 62(6):7484\u20137505","journal-title":"Mol Neurobiol"},{"issue":"12","key":"12011_CR67","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.4103\/NRR.NRR-D-24-00980","volume":"20","author":"DM Hermann","year":"2025","unstructured":"Hermann DM, Giebel B (2025) Extracellular vesicles: multiple signaling capabilities and translation into promising therapeutic targets to promote neuronal plasticity. Neural regeneration Res 20(12):3521\u20133522","journal-title":"Neural regeneration Res"},{"key":"12011_CR68","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.2147\/IJN.S502591","volume":"20","author":"X Su","year":"2025","unstructured":"Su X, Wang H, Li Q, Chen Z (2025) Extracellular Vesicles: A Review of Their Therapeutic Potentials, Sources, Biodistribution, and Administration Routes. Int J Nanomed 20:3175\u20133199","journal-title":"Int J Nanomed"},{"key":"12011_CR69","doi-asserted-by":"publisher","first-page":"1006118","DOI":"10.37349\/en.2025.1006118","volume":"4","author":"MA Mimi","year":"2025","unstructured":"Mimi MA, Hasan MM (2025) Extracellular vesicles in neurological disorders: emerging roles and underlying molecular mechanisms. Explor Neurosci 4:1006118","journal-title":"Explor Neurosci"},{"key":"12011_CR70","doi-asserted-by":"crossref","unstructured":"Jin Y, Zhang Y, Song M, Zhou J, Zhang H, Ding Y (2026) Engineered exosomes as precision tools for brain-targeted drug delivery and treatment of central nervous system diseases. Cell Biomaterials 100344","DOI":"10.1016\/j.celbio.2025.100344"},{"key":"12011_CR71","doi-asserted-by":"publisher","first-page":"106298","DOI":"10.1016\/j.bbi.2026.106298","volume":"134","author":"Q Fu","year":"2026","unstructured":"Fu Q, Li Y, Li X, Cheng Y, Du Y, Liang J (2026) miR-322-5p mediates maternal immune activation-induced schizophrenia-like behaviors via regulation of the BDNF\/TrkB\/AKT signaling pathway. Brain Behav Immun 134:106298","journal-title":"Brain Behav Immun"},{"issue":"1","key":"12011_CR72","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41398-025-03469-2","volume":"15","author":"Q Fu","year":"2025","unstructured":"Fu Q, Qiu R, Tang Q, Li X, Li Y, Qin Y et al (2025) Exosomes from high-altitude cerebral edema patients induce cognitive dysfunction by altering oxidative stress responses in mice. Translational psychiatry 15(1):253","journal-title":"Translational psychiatry"},{"key":"12011_CR73","doi-asserted-by":"crossref","unstructured":"Fonseka O, Gare SR, Chen X, Zhang J, Alatawi NH, Ross C et al (2025) Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential. Cells 14(5)","DOI":"10.3390\/cells14050324"},{"issue":"6","key":"12011_CR74","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.2174\/1570159X20666211231090659","volume":"20","author":"S Abdi","year":"2022","unstructured":"Abdi S, Javanmehr N, Ghasemi-Kasman M, Bali HY, Pirzadeh M (2022) Stem Cell-based Therapeutic and Diagnostic Approaches in Alzheimer\u2019s Disease. Curr Neuropharmacol 20(6):1093\u20131115","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"12011_CR75","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41392-024-02104-8","volume":"10","author":"X Ma","year":"2025","unstructured":"Ma X, Huang T, Chen X, Li Q, Liao M, Fu L et al (2025) Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics. Signal Transduct Target therapy 10(1):63","journal-title":"Signal Transduct Target therapy"},{"issue":"1","key":"12011_CR76","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10048-025-00803-0","volume":"26","author":"ZI Bahdar","year":"2025","unstructured":"Bahdar ZI, Abu-El-Rub E, Almazari R, Alzu\u2019bi A, Al-Zoubi RM (2025) The molecular mechanism of nitric oxide in memory consolidation and its role in the pathogenesis of memory-related disorders. Neurogenetics 26(1):22","journal-title":"Neurogenetics"},{"issue":"3","key":"12011_CR77","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ana.22487","volume":"70","author":"JS Lunn","year":"2011","unstructured":"Lunn JS, Sakowski SA, Hur J, Feldman EL (2011) Stem cell technology for neurodegenerative diseases. Ann Neurol 70(3):353\u2013361","journal-title":"Ann Neurol"},{"key":"12011_CR78","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-3-319-74470-4_5","volume":"1056","author":"K Sugaya","year":"2018","unstructured":"Sugaya K, Vaidya M (2018) Stem Cell Therapies for Neurodegenerative Diseases. Adv Exp Med Biol 1056:61\u201384","journal-title":"Adv Exp Med Biol"},{"key":"12011_CR79","doi-asserted-by":"crossref","unstructured":"Sivandzade F, Cucullo L (2021) Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview. Int J Mol Sci 22(4)","DOI":"10.3390\/ijms22042153"},{"key":"12011_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-10-1","volume":"10","author":"M Politis","year":"2012","unstructured":"Politis M, Lindvall O (2012) Clinical application of stem cell therapy in Parkinson\u2019s disease. BMC Med 10:1","journal-title":"BMC Med"},{"issue":"1","key":"12011_CR81","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/1673-5374.264446","volume":"15","author":"T Stoddard-Bennett","year":"2020","unstructured":"Stoddard-Bennett T, Pera RR (2020) Stem cell therapy for Parkinson\u2019s disease: safety and modeling. Neural regeneration Res 15(1):36\u201340","journal-title":"Neural regeneration Res"},{"key":"12011_CR82","doi-asserted-by":"crossref","unstructured":"Guatteo E, Berretta N, Monda V, Ledonne A, Mercuri NB (2022) Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson\u2019s Disease. Int J Mol Sci 23(9)","DOI":"10.3390\/ijms23094508"},{"key":"12011_CR83","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fcell.2020.00463","volume":"8","author":"ES \u00c1sgr\u00edmsd\u00f3ttir","year":"2020","unstructured":"\u00c1sgr\u00edmsd\u00f3ttir ES, Arenas E (2020) Midbrain Dopaminergic Neuron Development at the Single Cell Level: In vivo and in Stem Cells. Front cell Dev biology 8:463","journal-title":"Front cell Dev biology"},{"issue":"4","key":"12011_CR84","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1043-6618(03)00037-9","volume":"47","author":"O Lindvall","year":"2003","unstructured":"Lindvall O (2003) Stem cells for cell therapy in Parkinson\u2019s disease. Pharmacol Res 47(4):279\u2013287","journal-title":"Pharmacol Res"},{"issue":"2","key":"12011_CR85","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41583-019-0257-7","volume":"21","author":"M Parmar","year":"2020","unstructured":"Parmar M, Grealish S, Henchcliffe C (2020) The future of stem cell therapies for Parkinson disease. Nat Rev Neurosci 21(2):103\u2013115","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"12011_CR86","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4252\/wjsc.v12.i8.787","volume":"12","author":"XY Liu","year":"2020","unstructured":"Liu XY, Yang LP, Zhao L (2020) Stem cell therapy for Alzheimer\u2019s disease. World J stem cells 12(8):787\u2013802","journal-title":"World J stem cells"},{"issue":"1","key":"12011_CR87","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12017-026-08905-0","volume":"28","author":"P Zou","year":"2026","unstructured":"Zou P, Huang Z, Zhang Y, Zong X, Zhang Q (2026) Myelin Lipid Reserves as a Conditional Metabolic Buffer: Implications for Alzheimer\u2019s Disease and Ischemic Stroke. Neuromol Med 28(1):7","journal-title":"Neuromol Med"},{"key":"12011_CR88","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fncel.2017.00055","volume":"11","author":"Y Yang","year":"2017","unstructured":"Yang Y, Ye Y, Su X, He J, Bai W, He X (2017) MSCs-Derived Exosomes and Neuroinflammation, Neurogenesis and Therapy of Traumatic Brain Injury. Front Cell Neurosci 11:55","journal-title":"Front Cell Neurosci"},{"key":"12011_CR89","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F, Xue G (2024) The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci 16:1347987","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"12011_CR90","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3233\/JAD-160406","volume":"54","author":"JM Kang","year":"2016","unstructured":"Kang JM, Yeon BK, Cho S-J, Suh Y-H (2016) Stem cell therapy for Alzheimer\u2019s disease: a review of recent clinical trials. J Alzheimer\u2019s Disease 54(3):879\u2013889","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"1","key":"12011_CR91","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13287-017-0567-5","volume":"8","author":"T Duncan","year":"2017","unstructured":"Duncan T, Valenzuela M (2017) Alzheimer\u2019s disease, dementia, and stem cell therapy. Stem Cell Res Ther 8(1):111","journal-title":"Stem Cell Res Ther"},{"key":"12011_CR92","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-981-15-4370-8_4","volume":"1266","author":"F Han","year":"2020","unstructured":"Han F, Bi J, Qiao L, Arancio O (2020) Stem Cell Therapy for Alzheimer\u2019s Disease. Adv Exp Med Biol 1266:39\u201355","journal-title":"Adv Exp Med Biol"},{"key":"12011_CR93","doi-asserted-by":"publisher","first-page":"e20240147","DOI":"10.1590\/1980-5764-dn-2024-0147","volume":"18","author":"H Feizi","year":"2024","unstructured":"Feizi H, Hosseini MS, Seyedi-Sahebari S, Karimi H, Mosaddeghi-Heris R, Sadigh-Eteghad S et al (2024) A systematic review of clinical efficacy and safety of cell-based therapies in Alzheimer\u2019s disease. Dement neuropsychologia 18:e20240147","journal-title":"Dement neuropsychologia"},{"issue":"8","key":"12011_CR94","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/14712598.2018.1503248","volume":"18","author":"L Mazzini","year":"2018","unstructured":"Mazzini L, Ferrari D, Andjus PR, Buzanska L, Cantello R, De Marchi F et al (2018) Advances in stem cell therapy for amyotrophic lateral sclerosis. Expert Opin Biol Ther 18(8):865\u2013881","journal-title":"Expert Opin Biol Ther"},{"issue":"8","key":"12011_CR95","doi-asserted-by":"publisher","first-page":"E756","DOI":"10.1073\/pnas.1222361110","volume":"110","author":"HP Phatnani","year":"2013","unstructured":"Phatnani HP, Guarnieri P, Friedman BA, Carrasco MA, Muratet M, O\u2019Keeffe S et al (2013) Intricate interplay between astrocytes and motor neurons in ALS. Proc Natl Acad Sci USA 110(8):E756\u2013E765","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"12011_CR96","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1249\/MSS.0000000000003650","volume":"57","author":"C Wu","year":"2025","unstructured":"Wu C, Zou P, Zhu L, Feng S, Deng Q, Liu TC et al (2025) Treadmill Exercise Mitigates Alzheimer\u2019s Pathology by Modulating Glial Polarization and Reducing Oligodendrocyte Precursor Cell Perivascular Clustering. Med Sci Sports Exerc 57(6):1148\u20131160","journal-title":"Med Sci Sports Exerc"},{"issue":"1\u20132","key":"12011_CR97","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jns.2007.05.016","volume":"265","author":"L Mazzini","year":"2008","unstructured":"Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N et al (2008) Stem cell treatment in Amyotrophic Lateral Sclerosis. J Neurol Sci 265(1\u20132):78\u201383","journal-title":"J Neurol Sci"},{"issue":"8","key":"12011_CR98","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1080\/01616412.2021.1893564","volume":"43","author":"G Je","year":"2021","unstructured":"Je G, Keyhanian K, Ghasemi M (2021) Overview of stem cells therapy in amyotrophic lateral sclerosis. Neurol Res 43(8):616\u2013632","journal-title":"Neurol Res"},{"key":"12011_CR99","first-page":"11","volume":"4","author":"Z Mao","year":"2015","unstructured":"Mao Z, Zhang S, Chen H (2015) Stem cell therapy for amyotrophic lateral sclerosis. Cell regeneration (London England) 4:11","journal-title":"Cell regeneration (London England)"},{"issue":"7","key":"12011_CR100","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nbt1119","volume":"23","author":"S Goldman","year":"2005","unstructured":"Goldman S (2005) Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol 23(7):862\u2013871","journal-title":"Nat Biotechnol"},{"key":"12011_CR101","doi-asserted-by":"publisher","first-page":"1738589","DOI":"10.3389\/fimmu.2026.1738589","volume":"17","author":"L Zhu","year":"2026","unstructured":"Zhu L, Huang S, Chen W, Li K, Sheng J (2026) Cytokines and related signaling pathways in traumatic brain injury. Front Immunol 17:1738589","journal-title":"Front Immunol"},{"key":"12011_CR102","doi-asserted-by":"crossref","unstructured":"Aleemardani M, Zare P, Seifalian A, Bagher Z, Seifalian AM (2021) Graphene-Based Materials Prove to Be a Promising Candidate for Nerve Regeneration Following Peripheral Nerve Injury. Biomedicines 10(1)","DOI":"10.3390\/biomedicines10010073"},{"issue":"1","key":"12011_CR103","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13024-025-00861-w","volume":"20","author":"Z Huang","year":"2025","unstructured":"Huang Z, Zhang Y, Zou P, Zong X, Zhang Q (2025) Myelin dysfunction in aging and brain disorders: mechanisms and therapeutic opportunities. Mol neurodegeneration 20(1):69","journal-title":"Mol neurodegeneration"},{"issue":"1","key":"12011_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-018-0812-z","volume":"18","author":"NM Weston","year":"2018","unstructured":"Weston NM, Sun D (2018) The Potential of Stem Cells in Treatment of Traumatic Brain Injury. Curr Neurol Neurosci Rep 18(1):1","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"12011_CR105","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3171\/2009.4.JNS081087","volume":"112","author":"RM Richardson","year":"2010","unstructured":"Richardson RM, Singh A, Sun D, Fillmore HL, Dietrich DW 3rd, Bullock MR (2010) Stem cell biology in traumatic brain injury: effects of injury and strategies for repair. J Neurosurg 112(5):1125\u20131138","journal-title":"J Neurosurg"},{"key":"12011_CR106","doi-asserted-by":"crossref","unstructured":"Schepici G, Silvestro S, Bramanti P, Mazzon E (2020) Traumatic Brain Injury and Stem Cells: An Overview of Clinical Trials, the Current Treatments and Future Therapeutic Approaches. Med (Kaunas Lithuania) 56(3)","DOI":"10.3390\/medicina56030137"},{"key":"12011_CR107","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbr.2016.12.039","volume":"340","author":"A Dekmak","year":"2018","unstructured":"Dekmak A, Mantash S, Shaito A, Toutonji A, Ramadan N, Ghazale H et al (2018) Stem cells and combination therapy for the treatment of traumatic brain injury. Behav Brain Res 340:49\u201362","journal-title":"Behav Brain Res"},{"key":"12011_CR108","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fneur.2017.00028","volume":"8","author":"A Hasan","year":"2017","unstructured":"Hasan A, Deeb G, Rahal R, Atwi K, Mondello S, Marei HE et al (2017) Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury. Front Neurol 8:28","journal-title":"Front Neurol"},{"key":"12011_CR109","doi-asserted-by":"crossref","unstructured":"Gazdic M, Volarevic V, Harrell CR, Fellabaum C, Jovicic N, Arsenijevic N et al (2018) Stem Cells Therapy for Spinal Cord Injury. Int J Mol Sci 19(4)","DOI":"10.3390\/ijms19041039"},{"issue":"11","key":"12011_CR110","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1172\/JCI64124","volume":"122","author":"AJ Mothe","year":"2012","unstructured":"Mothe AJ, Tator CH (2012) Advances in stem cell therapy for spinal cord injury. J Clin Investig 122(11):3824\u20133834","journal-title":"J Clin Investig"},{"key":"12011_CR111","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13578-020-00475-3","volume":"10","author":"LL Liau","year":"2020","unstructured":"Liau LL, Looi QH, Chia WC, Subramaniam T, Ng MH, Law JX (2020) Treatment of spinal cord injury with mesenchymal stem cells. Cell bioscience 10:112","journal-title":"Cell bioscience"},{"issue":"3","key":"12011_CR112","doi-asserted-by":"publisher","first-page":"256","DOI":"10.5853\/jos.2016.01263","volume":"18","author":"OY Bang","year":"2016","unstructured":"Bang OY, Kim EH, Cha JM, Moon GJ (2016) Adult Stem Cell Therapy for Stroke: Challenges and Progress. J stroke 18(3):256\u2013266","journal-title":"J stroke"},{"issue":"8","key":"12011_CR113","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1161\/STROKEAHA.110.599654","volume":"42","author":"O Lindvall","year":"2011","unstructured":"Lindvall O, Kokaia Z (2011) Stem cell research in stroke: how far from the clinic? Stroke 42(8):2369\u20132375","journal-title":"Stroke"},{"issue":"7","key":"12011_CR114","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1747-4949.2012.00797.x","volume":"7","author":"JS Lees","year":"2012","unstructured":"Lees JS, Sena ES, Egan KJ, Antonic A, Koblar SA, Howells DW et al (2012) Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis. Int J stroke: official J Int Stroke Soc 7(7):582\u2013588","journal-title":"Int J stroke: official J Int Stroke Soc"},{"key":"12011_CR115","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fneur.2018.00034","volume":"9","author":"HE Marei","year":"2018","unstructured":"Marei HE, Hasan A, Rizzi R, Althani A, Afifi N, Cenciarelli C et al (2018) Potential of Stem Cell-Based Therapy for Ischemic Stroke. Front Neurol 9:34","journal-title":"Front Neurol"},{"key":"12011_CR116","doi-asserted-by":"publisher","first-page":"468748","DOI":"10.1155\/2014\/468748","volume":"2014","author":"L Hao","year":"2014","unstructured":"Hao L, Zou Z, Tian H, Zhang Y, Zhou H, Liu L (2014) Stem cell-based therapies for ischemic stroke. Biomed Res Int 2014:468748","journal-title":"Biomed Res Int"},{"issue":"Suppl 2","key":"12011_CR117","first-page":"S139","volume":"4","author":"R Meamar","year":"2013","unstructured":"Meamar R, Dehghani L, Ghasemi M, Khorvash F, Shaygannejad V (2013) Stem cell therapy in stroke: a review literature. Int J Prev Med 4(Suppl 2):S139\u2013S146","journal-title":"Int J Prev Med"},{"issue":"1","key":"12011_CR118","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s40001-024-01987-1","volume":"29","author":"R Rahimi Darehbagh","year":"2024","unstructured":"Rahimi Darehbagh R, Seyedoshohadaei SA, Ramezani R, Rezaei N (2024) Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives. Eur J Med Res 29(1):386","journal-title":"Eur J Med Res"},{"key":"12011_CR119","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.brainres.2012.04.039","volume":"1464","author":"S Wang","year":"2012","unstructured":"Wang S, Okun MS, Suslov O, Zheng T, McFarland NR, Vedam-Mai V et al (2012) Neurogenic potential of progenitor cells isolated from postmortem human Parkinsonian brains. Brain Res 1464:61\u201372","journal-title":"Brain Res"},{"issue":"1","key":"12011_CR120","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00109-025-02613-1","volume":"104","author":"J Isakovi\u0107","year":"2025","unstructured":"Isakovi\u0107 J, Athanassiadis A, Khubeis M (2025) Stem cells strike back: advancements in Alzheimer\u2019s and Parkinson\u2019s disease treatment and modeling efforts from 2019 to 2024. J Mol Med 104(1):2","journal-title":"J Mol Med"},{"issue":"1","key":"12011_CR121","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s13287-022-03104-7","volume":"13","author":"L Liang","year":"2022","unstructured":"Liang L, Tian Y, Feng L, Wang C, Feng G, Stacey GN et al (2022) Single-cell transcriptomics reveals the cell fate transitions of human dopaminergic progenitors derived from hESCs. Stem Cell Res Ther 13(1):412","journal-title":"Stem Cell Res Ther"},{"key":"12011_CR122","doi-asserted-by":"publisher","first-page":"1432841","DOI":"10.3389\/fimmu.2024.1432841","volume":"15","author":"R Peng","year":"2024","unstructured":"Peng R, Zhang L, Xie Y, Guo S, Cao X, Yang M (2024) Spatial multi-omics analysis of the microenvironment in traumatic spinal cord injury: a narrative review. Front Immunol 15:1432841","journal-title":"Front Immunol"},{"issue":"1","key":"12011_CR123","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s13023-025-03959-y","volume":"20","author":"Q Fu","year":"2025","unstructured":"Fu Q, Qiu R, Li S, Qin Y, Lu Z, Liyao S et al (2025) ECHS1: pathogenic mechanisms, experimental models, and emerging therapeutic strategies. Orphanet J Rare Dis 20(1):430","journal-title":"Orphanet J Rare Dis"},{"key":"12011_CR124","doi-asserted-by":"publisher","first-page":"115134","DOI":"10.1016\/j.intimp.2025.115134","volume":"162","author":"P Asadi-Sarabi","year":"2025","unstructured":"Asadi-Sarabi P, Rismani E, Shabanpouremam M, Hendi Z, Nikoubin B, Rahimi S et al (2025) Hypoimmunogenic pluripotent stem cells: A game-changer in cell-based regenerative medicine. Int Immunopharmacol 162:115134","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"12011_CR125","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s10142-025-01810-y","volume":"26","author":"N Roy","year":"2026","unstructured":"Roy N, Debnath P, Srivastava S, Gaur HS (2026) Recent developments in CRISPR\/Cas9 genome editing research for edible fungiculture. Funct Integr Genom 26(1):36","journal-title":"Funct Integr Genom"},{"issue":"11","key":"12011_CR126","doi-asserted-by":"publisher","first-page":"108282","DOI":"10.1016\/j.isci.2023.108282","volume":"26","author":"W Cheng","year":"2023","unstructured":"Cheng W, Xu C, Su Y, Shen Y, Yang Q, Zhao Y et al (2023) Engineered Extracellular Vesicles: A potential treatment for regeneration. iScience 26(11):108282","journal-title":"iScience"},{"key":"12011_CR127","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.brainresbull.2021.08.002","volume":"176","author":"J Samal","year":"2021","unstructured":"Samal J, Segura T (2021) Injectable biomaterial shuttles for cell therapy in stroke. Brain Res Bull 176:25\u201342","journal-title":"Brain Res Bull"},{"issue":"2","key":"12011_CR128","doi-asserted-by":"publisher","first-page":"100176","DOI":"10.1016\/j.jnrt.2024.100176","volume":"13","author":"W Gao","year":"2025","unstructured":"Gao W, Jing S, He C, Saberi H, Sharma HS, Han F et al (2025) Advancements in neurodegenerative diseases: Pathogenesis and novel neurorestorative interventions. J Neurorestoratology 13(2):100176","journal-title":"J Neurorestoratology"},{"issue":"12","key":"12011_CR129","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1002\/mds.70028","volume":"40","author":"MC Schiess","year":"2025","unstructured":"Schiess MC, Suescun J, Martinez-Lemus JD, Green C, Thomas TS, Shahnawaz M et al (2025) Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for Parkinson\u2019s Disease: A Randomized Trial. Mov disorders: official J Mov Disorder Soc 40(12):2688\u20132699","journal-title":"Mov disorders: official J Mov Disorder Soc"},{"issue":"4","key":"12011_CR130","doi-asserted-by":"publisher","first-page":"272","DOI":"10.12779\/dnd.2025.24.4.272","volume":"24","author":"NK Lee","year":"2025","unstructured":"Lee NK, Jang H, Choi Y, Hwangbo S, Lee S, Lee JI et al (2025) Mesenchymal Stem Cells With Adjuvant Dexamethasone in Patients With Alzheimer\u2019s Disease: A Phase IIa Trial. Dement neurocognitive disorders 24(4):272\u2013285","journal-title":"Dement neurocognitive disorders"},{"issue":"24","key":"12011_CR131","doi-asserted-by":"publisher","first-page":"e2294","DOI":"10.1212\/WNL.0000000000008620","volume":"93","author":"JD Berry","year":"2019","unstructured":"Berry JD, Cudkowicz ME, Windebank AJ, Staff NP, Owegi M, Nicholson K et al (2019) NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results. Neurology 93(24):e2294\u2013e305","journal-title":"Neurology"},{"issue":"13","key":"12011_CR132","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1089\/scd.2017.0009","volume":"26","author":"JD Sinden","year":"2017","unstructured":"Sinden JD, Hicks C, Stroemer P, Vishnubhatla I, Corteling R (2017) Human Neural Stem Cell Therapy for Chronic Ischemic Stroke: Charting Progress from Laboratory to Patients. Stem Cells Dev 26(13):933\u2013947","journal-title":"Stem Cells Dev"},{"issue":"4","key":"12011_CR133","doi-asserted-by":"publisher","first-page":"265","DOI":"10.13004\/kjnt.2025.21.e36","volume":"21","author":"S Kwon","year":"2025","unstructured":"Kwon S, Kang SH, Ko MJ, Lee BJ, Kwon WK, Jeon SR et al (2025) Intramedullary Neural Stem Cell Transplantation in Spinal Cord Injury: Timing, Targets, and Techniques. Korean J neurotrauma 21(4):265\u2013277","journal-title":"Korean J neurotrauma"},{"key":"12011_CR134","doi-asserted-by":"publisher","first-page":"1435461","DOI":"10.3389\/fcell.2024.1435461","volume":"12","author":"A G\u00f3rska","year":"2024","unstructured":"G\u00f3rska A, Trubalski M, Borowski B, Brachet A, Szyma\u0144czyk S, Markiewicz R (2024) Navigating stem cell culture: insights, techniques, challenges, and prospects. Front cell Dev biology 12:1435461","journal-title":"Front cell Dev biology"},{"issue":"7","key":"12011_CR135","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.ymthe.2022.05.005","volume":"30","author":"M Chhina","year":"2022","unstructured":"Chhina M, Drago D, Ndu A (2022) Planning for progress: A US regulatory approach to advancing the clinical development of gene therapies. Mol therapy: J Am Soc Gene Therapy 30(7):2397\u20132400","journal-title":"Mol therapy: J Am Soc Gene Therapy"},{"issue":"1","key":"12011_CR136","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-025-02313-9","volume":"10","author":"X Han","year":"2025","unstructured":"Han X, Liao R, Li X, Zhang C, Huo S, Qin L et al (2025) Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. Signal Transduct Target therapy 10(1):262","journal-title":"Signal Transduct Target therapy"},{"key":"12011_CR137","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fneur.2015.00155","volume":"6","author":"J Boltze","year":"2015","unstructured":"Boltze J, Arnold A, Walczak P, Jolkkonen J, Cui L, Wagner DC (2015) The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke. Front Neurol 6:155","journal-title":"Front Neurol"},{"issue":"1","key":"12011_CR138","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/ijms.21666","volume":"15","author":"V Volarevic","year":"2018","unstructured":"Volarevic V, Markovic BS, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N et al (2018) Ethical and Safety Issues of Stem Cell-Based Therapy. Int J Med Sci 15(1):36\u201345","journal-title":"Int J Med Sci"},{"issue":"3","key":"12011_CR139","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s11033-014-3020-1","volume":"41","author":"A Salimi","year":"2014","unstructured":"Salimi A, Nadri S, Ghollasi M, Khajeh K, Soleimani M (2014) Comparison of different protocols for neural differentiation of human induced pluripotent stem cells. Mol Biol Rep 41(3):1713\u20131721","journal-title":"Mol Biol Rep"},{"key":"12011_CR140","doi-asserted-by":"publisher","unstructured":"Bauer SR (2004) Stem Cell-based Products in Medicine: FDA Regulatory Considerations: Handbook of Stem Cells 805\u2013\u2009814. https:\/\/doi.org\/10.1016\/B978-012436643-5\/50163-2. Epub 2007 Sep 28","DOI":"10.1016\/B978-012436643-5\/50163-2"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12011-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12011-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12011-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:03:08Z","timestamp":1779883388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12011-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12011"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12011-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"6 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}],"article-number":"842"}}